Associations between human leukocyte antigen polymorphisms and hypersensitivity to antiretroviral therapy in patients with human immunodeficiency virus: a meta-analysis.
Kun HuQian XiangZhe WangGuang-Yan MuZhuo ZhangLing-Yue MaQiu-Fen XieShu-Qing ChenShuang ZhouXiao-Dan ZhangYi Min CuiPublished in: BMC infectious diseases (2019)
The findings of this meta-analysis indicated patients carrying HLA-A *24, HLA-B *18, *35, *39, *51, *81, HLA-C *04 were associated with a higher risk of hypersensitivity. Conversely, subjects carrying HLA-B *15, HLA-C *02, *03, *07, HLA-DRB1 *05, *15 were associated with a reduced risk of hypersensitivity.
Keyphrases
- human immunodeficiency virus
- antiretroviral therapy
- hiv infected
- hepatitis c virus
- systematic review
- end stage renal disease
- drug induced
- hiv positive
- hiv aids
- hiv infected patients
- endothelial cells
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- patient reported outcomes
- men who have sex with men